Improving kidney transplantation outcome with Renaparin® for patients with End-Stage Renal Disease by attenuating graft ischemia reperfusion injury

Project Information

Renaparin

Grant agreement ID: 756195

DOI 10.3030/756195

Project closed

EC signature date 2 February 2017

Start date 1 March 2017

End date 31 May 2020

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 2 362 681,25

EU contribution € 2 362 681,25

Coordinated by

CORLINE BIOMEDICAL AB
Sweden